BR112021020144A2 - Transposição de construções de ácidos nucleicos em genomas eucarióticos com uma transposase de amyelois - Google Patents

Transposição de construções de ácidos nucleicos em genomas eucarióticos com uma transposase de amyelois

Info

Publication number
BR112021020144A2
BR112021020144A2 BR112021020144A BR112021020144A BR112021020144A2 BR 112021020144 A2 BR112021020144 A2 BR 112021020144A2 BR 112021020144 A BR112021020144 A BR 112021020144A BR 112021020144 A BR112021020144 A BR 112021020144A BR 112021020144 A2 BR112021020144 A2 BR 112021020144A2
Authority
BR
Brazil
Prior art keywords
amyelois
transposase
transposition
nucleic acid
gene
Prior art date
Application number
BR112021020144A
Other languages
English (en)
Inventor
Jeremy Minshull
Maggie Lee
Sridhar Govindarajan
Original Assignee
Dna Twopointo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dna Twopointo Inc filed Critical Dna Twopointo Inc
Publication of BR112021020144A2 publication Critical patent/BR112021020144A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/007—Vector systems having a special element relevant for transcription cell cycle specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Ticket-Dispensing Machines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

transposição de construções de ácidos nucleicos em genomas eucarióticos com uma transposase de amyelois. a presente invenção fornece vetores polinucleotídicos para alta expressão de genes heterólogos. alguns vetores compreendem adicionalmente novos transposons e transposases que melhoram ainda mais a expressão. além disso, são divulgados vetores que podem ser usados em um sistema de transferência de genes para a introdução estável de ácidos nucleicos no dna de uma célula. os sistemas de transferência de genes podem ser usados em métodos, por exemplo, expressão gênica, bioprocessamento, terapia gênica, mutagênese por inserção ou descoberta de genes.
BR112021020144A 2019-04-08 2020-04-07 Transposição de construções de ácidos nucleicos em genomas eucarióticos com uma transposase de amyelois BR112021020144A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962831097P 2019-04-08 2019-04-08
US201962873342P 2019-07-12 2019-07-12
US202062990568P 2020-03-17 2020-03-17
PCT/US2020/027078 WO2020210237A1 (en) 2019-04-08 2020-04-07 Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois

Publications (1)

Publication Number Publication Date
BR112021020144A2 true BR112021020144A2 (pt) 2021-12-14

Family

ID=72663758

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021020144A BR112021020144A2 (pt) 2019-04-08 2020-04-07 Transposição de construções de ácidos nucleicos em genomas eucarióticos com uma transposase de amyelois

Country Status (11)

Country Link
US (3) US11060109B2 (pt)
EP (1) EP3953479A4 (pt)
JP (1) JP7418469B2 (pt)
KR (1) KR20210144861A (pt)
CN (1) CN112513277A (pt)
AU (1) AU2020272667B2 (pt)
BR (1) BR112021020144A2 (pt)
CA (1) CA3125043A1 (pt)
IL (2) IL301621A (pt)
SG (1) SG11202107383RA (pt)
WO (1) WO2020210237A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020272667B2 (en) 2019-04-08 2023-07-06 Dna Twopointo Inc. Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois
KR20210143897A (ko) 2019-04-08 2021-11-29 디앤에이 투포인토 인크. 오리지아스로부터의 트랜스포사제를 이용한 핵산 작제물의 진핵세포로의 통합
EP3953480A4 (en) 2019-04-08 2023-01-11 Dna Twopointo Inc. TRANSPOSITION OF NUCLEIC ACIDS INTO EUKARYOTIC GENOMES WITH A TRANSPOSASE FROM HELIOTHIS
CA3173889A1 (en) 2020-05-04 2021-11-11 Saliogen Therapeutics, Inc. Transposition-based therapies
EP4314302A1 (en) * 2021-03-24 2024-02-07 Dna Twopointo Inc. Tetracycline-inducible expression systems
CN116445542A (zh) * 2022-01-10 2023-07-18 佛山汉腾生物科技有限公司 表达载体及其应用
WO2024068995A1 (en) 2022-09-30 2024-04-04 Boehringer Ingelheim International Gmbh Novel transposase system
CN116590341A (zh) * 2023-07-13 2023-08-15 山东维真生物科技有限公司 一种腺病毒-PiggyBac系统及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7560542B2 (en) 1999-05-07 2009-07-14 Monsanto Technology Llc Nucleic acid molecule SEQ ID NO. 68811 and other molecules associated with plants
US6518064B1 (en) * 2000-03-29 2003-02-11 The Regents Of The University Of California Pink bollworm expression system for commercially valuable protein production
US7932088B1 (en) 2005-04-25 2011-04-26 University Of Notre Dame Du Lac High efficiency transformation of Plasmodium falciparum by the lepidopteran transposon, piggyBac
WO2006122442A1 (en) * 2005-05-14 2006-11-23 Fudan University Piggybac as a tool for genetic manipulation and analysis in vertebrates
JP5897335B2 (ja) 2009-01-23 2016-03-30 エヌエスジーン・アクティーゼルスカブＮｓＧｅｎｅ Ａ／Ｓ 改良された細胞株及びカプセル化細胞生体送達におけるその使用
WO2010099301A2 (en) 2009-02-25 2010-09-02 The Johns Hopkins University Piggybac transposon variants and methods of use
DK2441831T3 (en) 2009-06-11 2018-12-03 Inter Univ Research Institute Corporation Research Organization Of Information And Systems PROCEDURE FOR PRODUCING PROTEIN
WO2012116274A2 (en) 2011-02-25 2012-08-30 Recombinetics, Inc. Genetically modified animals and methods for making the same
CN103547296B (zh) * 2011-03-11 2016-08-17 非营利性组织佛兰芒综合大学生物技术研究所 用于抑制和检测蛋白质的分子和方法
AU2014273418B2 (en) * 2013-04-29 2020-04-23 Biotalys NV Agrochemical compositions comprising antibodies binding to sphingolipids
US10041077B2 (en) * 2014-04-09 2018-08-07 Dna2.0, Inc. DNA vectors, transposons and transposases for eukaryotic genome modification
DK3129487T3 (da) * 2014-04-09 2020-11-30 Dna Twopointo Inc Forbedrede nukleinsyrekonstruktioner til eukaryot genekspression
EP3359671B1 (en) 2015-10-08 2021-08-18 Dna Twopointo Inc. Dna vectors, transposons and transposases for eukaryotic genome modification
AU2020272667B2 (en) * 2019-04-08 2023-07-06 Dna Twopointo Inc. Transposition of nucleic acid constructs into eukaryotic genomes with a transposase from amyelois
KR20210143897A (ko) 2019-04-08 2021-11-29 디앤에이 투포인토 인크. 오리지아스로부터의 트랜스포사제를 이용한 핵산 작제물의 진핵세포로의 통합
EP3953480A4 (en) 2019-04-08 2023-01-11 Dna Twopointo Inc. TRANSPOSITION OF NUCLEIC ACIDS INTO EUKARYOTIC GENOMES WITH A TRANSPOSASE FROM HELIOTHIS
WO2022051627A2 (en) * 2020-09-04 2022-03-10 Dna Twopointo Inc. Modifications of mammalian cells using artificial micro-rna to alter their properties and the compositions of their products

Also Published As

Publication number Publication date
CA3125043A1 (en) 2020-10-15
US20200318135A1 (en) 2020-10-08
SG11202107383RA (en) 2021-08-30
US20210324408A1 (en) 2021-10-21
AU2020272667B2 (en) 2023-07-06
IL287088A (en) 2021-12-01
JP2022527016A (ja) 2022-05-27
EP3953479A1 (en) 2022-02-16
EP3953479A4 (en) 2023-01-11
JP7418469B2 (ja) 2024-01-19
US11060109B2 (en) 2021-07-13
AU2020272667A1 (en) 2021-07-15
CN112513277A (zh) 2021-03-16
KR20210144861A (ko) 2021-11-30
IL287088B1 (en) 2023-05-01
US20220411816A1 (en) 2022-12-29
IL287088B2 (en) 2023-09-01
US11396662B2 (en) 2022-07-26
IL301621A (en) 2023-05-01
WO2020210237A1 (en) 2020-10-15

Similar Documents

Publication Publication Date Title
BR112021020144A2 (pt) Transposição de construções de ácidos nucleicos em genomas eucarióticos com uma transposase de amyelois
BR112021020143A2 (pt) Integração de construções de ácidos nucleicos com células eucarióticas com uma transposase de oryzias
US11578343B2 (en) CAS9 proteins including ligand-dependent inteins
US10301613B2 (en) Targeted remodeling of prokaryotic genomes using CRISPR-nickases
ES2888976T3 (es) Identificación no sesgada pangenómica de DSBs evaluada por secuenciación (GUIDE-Seq.)
US10612011B2 (en) Evolution of TALENs
BR112021012665A2 (pt) Polipeptídeos úteis para edição de genes e métodos de uso
WO2017062668A3 (en) Dna vectors, transposons and transposases for eukaryotic genome modification
US20180044659A1 (en) Methods and kits for fragmenting dna
WO2017024602A1 (zh) 一种测定非同源末端连接修复活性的方法
JP2018522544A (ja) 熱安定性ｃａｓ９ヌクレアーゼ
ES2690386T3 (es) Composición para escindir un ADN diana que comprende un ARN guía específico para el ADN diana y el ácido nucleico que codifica la proteína Cas o la propia proteína Cas, y sus usos
Zhang et al. Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporter
US20220243184A1 (en) ENGINEERED Cas-Transposon SYSTEM FOR PROGRAMMABLE AND SITE-DIRECTED DNA TRANSPOSITIONS
Javidi-Parsijani et al. No evidence of genome editing activity from Natronobacterium gregoryi Argonaute (NgAgo) in human cells
Vriend et al. Assaying break and nick-induced homologous recombination in mammalian cells using the DR-GFP reporter and Cas9 nucleases
BR112022002695A2 (pt) Nucleases guiadas por rna, fragmentos ativos e variantes das mesmas e métodos de uso
Sun et al. SunnyTALEN: A second‐generation TALEN system for human genome editing
BR112020025319A2 (pt) Composições, sistemas e métodos de amplificação baseada em crispr/cas e transposase
Zhang et al. A simple TALEN-based protocol for efficient genome-editing in Drosophila
Nievergelt et al. Efficient precision editing of endogenous Chlamydomonas reinhardtii genes with CRISPR-Cas
US20230032136A1 (en) Method for determination of 3d genome architecture with base pair resolution and further uses thereof
Wang et al. Research of methods to detect genomic mutations induced by CRISPR/Cas systems
Vinayak et al. Genetic manipulation of the Toxoplasma gondii genome by fosmid recombineering
Wei et al. An electroporation-free method based on Red recombineering for markerless deletion and genomic replacement in the Escherichia coli DH1 genome